[Rules for the histological evaluation of drug-induced liver lesions].
D001706:Biopsy; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis; D002746:Chlorpromazine / Q000009:adverse effects; D002779:Cholestasis / Q000139:chemically induced; D003276:Contraceptives, Oral / Q000009:adverse effects; D005260:Female; D006099:Granuloma / Q000139:chemically induced; D006221:Halothane; D006801:Humans; D008099:Liver / Q000473:pathology; D008107:Liver Diseases / Q000175:diagnosis; D008750:Methyldopa / Q000009:adverse effects; D009336:Necrosis; D010114:Oxyphenisatin Acetate / Q000009:adverse effects
D003276:Contraceptives, Oral; D008750:Methyldopa; D010114:Oxyphenisatin Acetate; D002746:Chlorpromazine; D006221:Halothane
Richtlinien für die histologische Beurteilung arzneimittelbedingter (medikamentöser) Leberschäden